| |
|
|
|
Aslan Pharmaceuticals Ltd ADR  
|
|
1.94 -1.14 (-0.37%) |
09-28 16:00 |
|
Open: |
2.19 |
Pre close: |
3.08 |
Target:
|
3.28 
|
|
High: |
2.2 |
Low: |
1.92 |
Resistance:
|
2.81
3.36
|
|
Volume: |
5,488,150 |
Market Cap: |
135M |
Support:
|
1.92
1.60
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.74
|
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
2.96 |
Signal(12,26,9): |
0.04 |
|
MA(100): |
2.96 |
Stochastic Oscillator |
%K(14,3):
|
30.90 |
|
MA(250): |
2.74  |
%D(3): |
54.92 |
|
Average Volume(K) |
3-Month: |
2283871
|
52-Week |
High:
|
6.75 |
|
10-Days: |
282569 |
Low: |
1.42 |
|
RSI |
RSI(14):
|
27.61 |
Change(%): |
2.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.475 |
Return on Equity (ttm) |
-53.7 |
Shares Out. (M) |
69.52 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-20.6 |
Shares Float (M) |
47.93 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
39.73 |
|
Forward EPS |
-0.280 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1590 |
|
Book Value (p.s.) |
1.580 |
EBITDA (p.s.) |
-0.287 |
P/E |
-4.08 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.23 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
